Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38

Haematologica

Volumn 95, Issue 3, 2010, Pages 514-517

  Pearce, Laurence ^a   Morgan, Liam ^a   Lin, Thet Thet ^a   Hewamana, Saman ^b   Matthews, R James ^a   Deaglio, Silvia ^c   Rowntree, Clare ^b   Fegan, Christopher ^b   Pepper, Christopher ^a   Brennan, Paul ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

CD38 negative; Chronic lymphocytic leukemia; Primary tumor cells

Indexed keywords

CD38 ANTIGEN; LENTIVIRUS VECTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA MODIFICATION; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LENTIVIRINAE; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE;

ANTIGENS, CD38; CELL PROLIFERATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC VECTORS; HUMANS; LENTIVIRUS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MEMBRANE GLYCOPROTEINS; TRANSDUCTION, GENETIC;

EID: 77949743196     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.014381     Document Type: Article

References (19)

1. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94(6):1840-7.
2. Morabito F, Mangiola M, Oliva B, Stelitano C, Callea V, Deaglio S, et al. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia. Leuk Res. 2001;25(11):927-32.
3. Morabito F, Damle RN, Deaglio S, Keating M, Ferrarini M, Chiorazzi N. The CD38 ectoenzyme family: advances in basic science and clinical practice. Mol Med. 2006; 12(11-12):342-4.
4. Durig J, Naschar M, Schmucker U, Renzing-Kohler K, Holter T, Huttmann A, et al. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia. 2002;16(1):30-5.
5. Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood. 2001;98(9):2633-9.
6. Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood. 2001;98(1):181-6.
7. Pepper C, Ward R, Lin TT, Brennan P, Starczynski J, Musson M, et al. Highly purified CD38+ and CD38- sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin. Leukemia. 2007;21(4):687-96.
8. McCabe D, Bacon L, O'Regan K, Condron C, O'Donnell JR, Murphy PT. CD38 expression on B-cell chronic lymphocytic leukemic cells is strongly correlated with vascular endothelial growth factor expression. Leukemia. 2004;18(3):649-50.
9. He Q, Beyers AD, Barclay AN, Williams AF. A role in transmembrane signaling for the cytoplasmic domain of the CD2 T lymphocyte surface antigen. Cell. 1988;54(7):979-84.
10. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C, et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther. 2002;13(7):803-13.
11. Qasim W, Mackey T, Sinclair J, Chatziandreou I, Kinnon C, Thrasher AJ, et al. Lentiviral vectors for T-cell suicide gene therapy: preservation of T-cell effector function after cytokine-mediated transduction. Mol Ther. 2007;15(2):355-60.
12. Pepper C, Lin TT, Pratt G, Hewamana S, Brennan P, Hiller L, et al. Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood. 2008;112(9):3807-17.
13. Qasim W, Gaspar HB, Thrasher AJ. Gene therapy for severe combined immune deficiency. Expert Rev Mol Med. 2004;6(13):1-15.
14. Hurez V, Dzialo-Hatton R, Oliver J, Matthews RJ, Weaver CT. Efficient adenovirus-mediated gene transfer into primary T cells and thymocytes in a new coxsackie/ adenovirus receptor transgenic model. BMC Immunol. 2002;3:4.
15. Deaglio S, Aydin S, Vaisitti T, Bergui L, Malavasi F. CD38 at the junction between prognostic marker and therapeutic target. Trends Mol Med. 2008; 14(5):210-8.
16. Frecha C, Costa C, Levy C, Negre D, Russell SJ, Maisner A, et al. Efficient and stable transduction of resting B-lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. Blood. 2009; 114(15):3173-80.
17. Van Bockstaele F, Pede V, Naessens E, Van Coppernolle S, Van Tendeloo V, Verhasselt B, et al. Efficient gene transfer in CLL by mRNA electroporation. Leukemia. 2008; 22(2):323-9.
18. Laurie KL, Blundell MP, Baxendale HE, Howe SJ, Sinclair J, Qasim W, et al. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector. Gene Ther. 2007;14(23):1623-31.
19. Zhang F, Thornhill SI, Howe SJ, Ulaganathan M, Schambach A, Sinclair J, et al. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood. 2007;110(5):1448-57.